Subscribe to RSS
DOI: 10.4103/2348-0548.173235
Glanzmann thrombasthenia and its perioperative management in head trauma: A rare and challenging situation
Publication History
Publication Date:
03 May 2018 (online)
Abstract
Glanzmann thrombasthenia is a rare inherited coagulation disorder, manifesting itself in early childhood as bleeding episodes. The patients with this disease may present with uncontrollable bleeding following trauma. We report a patient of Glanzmann syndrome with head injury, who presented to us following fall from stairs. Platelet transfusion is the mainstay of treatment in emergency situations. As patients generally have a history of platelet transfusion they may be refractory to the same. Leuko reduced or human leukocyte antigen matched platelets should be used. Recombinant factor VIIa can be used to control bleeding in refractory cases and in patients with antibodies against platelets. Anti-fibrinolytics can also be used as adjuvants. There is need of advanced perioperative coagulation screening spot tests in emergency trauma settings as routine coagulation tests may not be able to pick up the abnormality. Thromboelastography/thromboelastometry can be a great tool for perioperative management of such coagulation disorders.
-
REFERENCES
- 1 Glanzmann E. Hereditaire hamorrhagische thrombasthenic. Ein beitrag zur pathologie der blutplattchen. Jahrb Kinderheilkd 1918; 88: 1-42
- 2 Nair S, Ghosh K, Kulkarni B, Shetty S, Mohanty D. Glanzmann's thrombasthenia: Updated. Platelets 2002; 13: 387-93
- 3 Kannan M, Saxena R. Glanzmann's thrombasthenia: An overview. Clin Appl Thromb Hemost 2009; 15: 152-65
- 4 Franchini M, Lippi G. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia. Expert Rev Hematol 2014; 7: 733-40
- 5 Kessler CM. New products for managing inhibitors to coagulation factors: A focus on recombinant factor VIIa concentrate. Curr Opin Hematol 2000; 7: 408-13
- 6 Ovanesov MV, Panteleev MA, Sinauridze EI, Kireev DA, Plyushch OP, Kopylov KG. et al. Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution. Blood Coagul Fibrinolysis 2008; 19: 743-55
- 7 Alamelu J, Liesner R. Modern management of severe platelet function disorders. Br J Haematol 2010; 149: 813-23
- 8 Topal A, Kιlιçaslan A, Erol A, Çankaya B, Otelcioğlu S. Anaesthetic management with thromboelastography in a patient with Glanzmann thrombasthenia. Turk J Anaesth Reanim 2014; 42: 227-9
- 9 Chitlur M, Rivard GE, Lillicrap D, Mann K, Shima M, Young G. et al. Recommendations for performing thromboelastography/thromboelastometry in hemophilia: Communication from the SSC of the ISTH. J Thromb Haemost 2014; 12: 103-6
- 10 Lak M, Scharling B, Blemings A, Sharifian R, Maleki Z, Daraee A. et al. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram. Haemophilia 2008; 14: 103-10